The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Cascades releases its 2012 third quarter results

Thursday, November 08, 2012

Cascades releases its 2012 third quarter results06:30 EST Thursday, November 08, 2012 KINGSEY FALLS, QC, Nov. 8, 2012 /PRNewswire/ - Cascades Inc. (TSX: CAS), a leader in the recovery and manufacturing of green packaging and tissue paper products, announces its financial results for the three-month period ended September 30, 2012. Q3-2012 Financial Highlights Sales of $906 million (compared to $944 million in Q2-2012 (-4%) and $947 million in Q3-2011 (-4%)) Excluding specific items EBITDA of $78 million (compared to $84 million in Q2-2012 (-7%) and $79 million in Q3-2011 (-1%)) Net earnings per share of $0.07 (compared to net earnings of $0.08 in Q2-2012 and a net loss of $0.02 in Q3-2011) Including specific items EBITDA of $83 million (compared to $77 million in Q2-2012 (+8%) and $53 million in Q3-2011 (+57%)) Net earnings per share of $0.05 (compared to net earnings of $0.08 in Q2-2012 and a net loss of $0.21 in Q3-2011) Net debt of $1,542 million (compared to $1,585 million as at June 30, 2012), including $147 million of non-recourse debt Price increase announcement in our containerboard sector Strategic and Financial Initiatives Major investments in several of our folding carton and microlithography plants and announcement of the closure of the Lachute (Québec) folding carton plant Permanent closure of the napkin plant located on McNicoll Street in Toronto Greenpac project machine installation proceeding as planned with expected start-up in July 2013 Extension and amendment of existing revolving credit facility resulting in lower interest costs Establishment of a Small Shareholder Program for registered shareholders Mr. Alain Lemaire, President and Chief Executive Officer, had the following comments on the third quarter results and near-term outlook: "The results for our third quarter did not meet our expectations due to a strong Canadian dollar, operational issues, higher recycled office paper costs and a stronger seasonal decline in activity level in Europe. Our Tissue Papers Group continued to contribute positively but was impacted by the increase in the average cost of its raw materials, namely white grades recycled papers. Our Specialty Products Group posted stable results. In Europe, shipments decreased significantly. As previously highlighted, downtimes, which are usual during this period of the year, have been longer in 2012 due to important investments undertaken at certain mills and lower order inflows. Financial results of our Containerboard Group show a sequential increase. However these results should have been better given the decline in recycled paper costs. During the last few quarters, operational problems at two of our manufacturing mills resulted in higher production and external supply costs. Downtime taken in September to address these problems further contributed to subpar performance. As a result, we were not able to fully benefit from the usual seasonality inherent to the third quarter and from more favorable recycled fiber prices. In the short term, fundamentals in our sectors are positive. In the containerboard sector, the recent price hike announcement will contribute positively to our results during the next quarter with full implementation in the beginning of 2013. Demand in the tissue papers segment continues to be robust. The European market remains difficult but we are satisfied with progress made to improve our production assets following recent investments. Finally, we do not expect a significant increase in the level of recycled paper prices in the short term. For these reasons, prospects for the current quarter are encouraging despite the inherent seasonality associated with the month of December." Financial Summary Selected consolidated information       (in millions of Canadian dollars, except amounts per share) (unaudited) Q3/2012 Q3/2011 Q2/2012           Sales 906 947 944 Excluding specific items 1         Operating income before depreciation and amortization (OIBD or EBITDA)  78 79 84   Operating income  33 33 37   Net earnings (loss) 7 (2) 7   per common share $0.07 $(0.02) $0.08   Cash flow from continuing operations (adjusted)  44 61 40   Margin (OIBD or EBITDA) 8.6% 8.3% 8.9% As reported         Operating income before depreciation and amortization (OIBD or EBITDA) 83 53 77   Operating income 36 7 29   Net earnings (net loss) 5 (20) 7   per common share $0.05 $(0.21) $0.08   Cash flow from continuing operations (adjusted) 42 60 37 Note 1 - see the supplemental information on non-IFRS measures.                           Segmented OIBD excluding specific items       (in millions of Canadian dollars) (unaudited) Q3/2012 Q3/2011 Q2/2012           Packaging Products         Containerboard 26 27 23   Boxboard Europe 7 10 11   Specialty Products 15 13 15     48 50 49           Tissue Papers 35 18 39           Corporate Activities (5) 11 (4)           OIBD excluding specific items 78 79 84    Results analysis for the three-month period ended September 30, 2012 (compared to the previous year) In comparison with the same period last year, sales decreased by 4% to $906 million as of result of lower volumes, lower average selling prices and an unfavorable CAD/Euro exchange rate which more than offset the net impact of business acquisitions over divestitures and closures. Operating income, excluding specific items, remained stable compared to Q3-2011 at $33 million as the above-mentioned factors were counterbalanced by lower raw material costs. On a segmented basis, our three sectors in North America surpassed their 2011 third quarter's results. The third quarter is often softer in Europe and our Boxboard sector recorded lower operating income due to longer downtimes this year. When including specific items, the operating income amounted to $36 million in comparison to $7 million for the same period of last year. During the third quarter of 2011, foreign exchange gain on working capital items following the rapid depreciation of the Canadian dollar at the end of the quarter, combined with foreign exchange gain of approximately $14 million on the consideration received from the sale of Dopaco, had a significant impact on our operating income. In the third quarter of 2012, these specific items impacted our operating income and/or net earnings (before tax): a $6 million unrealized gain on financial instruments (impact on operating income and net earnings); a $1 million loss resulting from impairment charges (operating income and net earnings); a $2 million expense related to accelerated depreciation of assets due to restructuring measures (operating income and net earnings); a $5 million foreign exchange loss on long-term debt and financial instruments (net earnings). For further details, see the following tables on IFRS and non-IFRS measures reconciliation included herewith. Net earnings excluding specific items amounted to $7 million ($0.07 per share) in the third quarter of 2012 compared to a net loss of $2 million ($0.02 per share) for the same period in 2011. Including specific items, net earnings amounted to $5 million ($0.05 per share) compared to a net loss of $20 million ($0.21 per share) for the same quarter in 2011. Results analysis for the three-month period ended September 30, 2012 (compared to the previous quarter) In comparison to the previous quarter, sales decreased by 4% mostly due to the impact of lower volumes, lower average selling price, unfavorable foreign exchange rates and the impact of mill closures. Excluding specific items, operating income decreased by $4 million to reach $33 million primarily due to the above-mentioned factors that more than offset a decrease in raw material costs. Net earnings for the quarter remained stable at $7 million. Net debt decreased by $43 million to $1,542 million due to a favorable exchange rate with regard to our debt and free cash flows generated. Dividend on common shares and normal course issuer bid The Board of Directors of Cascades declared a quarterly dividend of $0.04 per share to be paid December 13, 2012 to shareholders of record at the close of business on November 30, 2012. This dividend paid by Cascades is an "eligible dividend" as per the Income Tax Act (Bill C-28, Canada). In the third quarter of 2012, Cascades purchased for cancellation 75,500 shares at an average price of $4.76 representing an aggregate amount of approximately $0.4 million. Conference call and additional information Management will comment the 2012 third quarter financial results during a conference call to be held today, November 8, 2012, at 10:00am ET. Financial analysts, investors, media and other interested individuals are invited to listen to the conference call by dialing 1-866-865-3087. The conference call, including the investor presentation, will also be broadcast live on the Cascades corporate website (www.cascades.com, tab Investors of the Home page). The broadcast replay will be available on the Cascades corporate website and by phone until November 16, 2012 by dialing 1-855-859-2056 and by using access code 34725598#. Founded in 1964, Cascades produces, converts and markets packaging and tissue products that are composed mainly of recycled fibres. The Corporation employs more than 12,000 employees, who work in more than 100 units located in North America and Europe. With its management philosophy, half a century of experience in recycling, and continuous efforts in research and development as driving forces, Cascades continues to serve its clients with innovative products. Cascades' shares trade on the Toronto Stock Exchange, under the ticker symbol CAS. Certain statements in this release, including statements regarding future results and performance, are forward-looking statements (as such term is defined under the Private Securities Litigation Reform Act of 1995) based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for the Corporation's products, increases in raw material costs, fluctuations in selling prices and adverse changes in general market and industry conditions and other factors listed in the Corporation's Securities and Exchange Commission filings. CONSOLIDATED BALANCE SHEETS (in millions of Canadian dollars) (unaudited) September 30, 2012 December 31, 2011 Assets     Current assets     Cash and cash equivalents 16 12 Accounts receivable 570       535 Current income tax assets 22 24 Inventories 494 516 Financial assets 28 6 Assets held for sale - 12   1,130 1,105 Long-term assets     Investments in associates and joint ventures 228 219 Property, plant and equipment 1,655 1,703 Intangible assets 196 185 Financial assets 11 25 Other assets 57 44 Deferred income tax assets 142 119 Goodwill and others 336 328   3,755 3,728 Liabilities and Equity     Current liabilities     Bank loans and advances 96 90 Trade and other payables 533 539 Current income tax liabilities 3 2 Current portion of provisions for contingencies and charges 5 5 Current portion of financial liabilities and other liabilities 92 20 Current portion of long-term debt 65 49   794 705 Long-term liabilities     Long-term debt 1,397 1,358 Provisions for contingencies and charges 32 33 Financial liabilities 43 111 Other liabilities 288 249 Deferred income tax liabilities 90 107   2,644 2,563 Equity attributable to Shareholders     Capital stock 482 486 Contributed surplus 16 14 Retained earnings 581 615 Accumulated other comprehensive loss (91) (86)   988 1,029 Non-controlling interest 123 136 Total equity 1,111 1,165   3,755 3,728 CONSOLIDATED STATEMENT OF EARNINGS   For the 3-month periods ended September 30, For the 9-month periods ended September  30, (in millions of Canadian dollars, except per share amounts and number of shares) (unaudited) 2012 2011 2012 2011 Sales       906       947 2,741 2,712 Cost of sales and expenses                       Cost of sales (including depreciation and amortization of $47 million for the 3-month period (2011-$46 million) and $141 million for the 9-month period (2011-$129 million))       781       848 2,361 2,428 Selling and administrative expenses       92       91 286 266 Gain on disposals and others       -       - (1) (10) Impairment charges and restructuring costs       1       15 6 20 Foreign exchange loss (gain)       2       (22) 2 (21) Loss (gain) on derivative financial instruments       (6)       8 (7) 7         870       940 2,647 2,690 Operating income       36       7 94 22 Financing expense       25       24 75 75 Foreign exchange loss (gain) on long-term debt and financial instruments       5       (5) (2) 5 Share of loss (earnings) of associates and joint ventures       1       (1) (3) (11) Profit (loss) before income taxes       5       (11) 24 (47) Provision for (recovery of) income taxes       1       10 7 (25) Net earnings (loss) from continuing operations including non-controlling interest for the period       4       (21) 17 (22) Net earnings (loss) from discontinued operations for the period       -       (2) (2) 113 Net earnings (loss) including non-controlling interest for the period       4       (23) 15 91 Net loss attributable to non-controlling interest       (1)       (3) (3) (3) Net earnings (loss) attributable to Shareholders for the period       5       (20) 18 94 Net earnings (loss) from continuing operations per common share                         Basic       $0.05       $(0.19) $0.21 $(0.20)   Diluted       $0.05       $(0.19) $0.21 $(0.20) Net earnings (loss) per common share                         Basic       $0.05       $(0.21) $0.19 $0.98   Diluted       $0.05       $(0.21) $0.19 $0.96 Weighted average basic number of common shares outstanding       94,056,848       95,986,989 94,223,991 96,317,941                         Net earnings (loss) attributable to Shareholders:                         Continuing operations       5       (18) 20 (19)   Discontinued operations       -       (2) (2) 113 Net earnings (loss)       5       (20) 18 94 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)   For the 3-month periods ended September 30, For the 9-month periods ended September 30, (in millions of Canadian dollars) (unaudited) 2012 2011 2012 2011 Net earnings (loss) including non-controlling interest for the period 4 (23) 15 91 Other comprehensive income (loss)           Translation adjustments             Change in foreign currency translation of self-sustaining foreign subsidiaries (13) 31 (18) 7     Change in foreign currency translation related to net investment hedging  activities 15 (33) 14 (14)     Income taxes (2) 5 (2) 2   Cash flow hedges             Change in fair value of foreign exchange forward contracts (10) (9) (7) (5)     Change in fair value of interest rate swaps 10 (7) 6 (8)     Change in fair value of commodity derivative financial instruments (4) 4 (3) (1)     Income taxes - 3 - 2   Actuarial loss on post-employment benefit obligations (36) (53) (61) (53)     Income taxes 10 14 17 14 Other comprehensive loss (30) (45) (54) (56) Comprehensive income (loss) including non-controlling interest for the period (26) (68) (39) 35 Comprehensive income (loss) attributable to non-controlling interest for the period (4) - (8) (2) Comprehensive income (loss) attributable to Shareholders for the period (22) (68) (31) 37           Comprehensive income (loss) attributable to Shareholders:             Continuing operations (22) (66) (29) (76)     Discontinued operations - (2) (2) 113 Comprehensive income (loss) (22) (68) (31) 37 CONSOLIDATED STATEMENTS OF EQUITY   For the 9-month period ended September 30, 2012 (in millions of Canadian dollars) (unaudited) Capital stock Contributed surplus Retained earnings Accumulated other comprehensive loss Total equity attributable to Shareholders Non- controlling interest Total equity Balance?Beginning of period 486 14 615 (86) 1,029 136 1,165   Comprehensive income (loss)                   Net earnings (loss) - - 18 - 18 (3) 15     Other comprehensive loss - - (44) (5) (49) (5) (54)   - - (26) (5) (31) (8) (39)   Dividends - - (11) - (11) - (11)   Stock options - 1 - - 1 - 1   Redemption of common shares (4) 1 - - (3) - (3)   Acquisition of non-controlling interest - - 3 - 3 (5) (2) Balance?End of period 482 16 581 (91) 988 123 1,111                                   For the 9-month period ended September 30, 2011 (in millions of Canadian dollars) (unaudited) Capital stock Contributed surplus Retained earnings Accumulated other comprehensive loss Total equity attributable to Shareholders Non- controlling interest Total equity Balance?Beginning of period 496 14 576 (37) 1,049 23 1,072   Comprehensive income (loss)                   Net earnings (loss) - - 94 - 94 (3) 91     Other comprehensive income (loss) - - (39) (18) (57) 1 (56)   - - 55 (18) 37 (2) 35   Dividends - - (12) - (12) - (12)   Stock options - (1) - - (1) - (1)   Redemption of common shares (7) - - - (7) - (7)   Business acquisitions - - - - - 129 129   Acquisition of non-controlling interest - - 1 - 1 (2) (1)   Dividends paid to non-controlling interest - - - - - (1) (1) Balance?End of period 489 13 620 (55) 1,067 147 1,214 CONSOLIDATED STATEMENTS OF CASH FLOWS   For the 3-month periods ended September 30, For the 9-month periods ended September  30, (in millions of Canadian dollars) (unaudited) 2012 2011 2012 2011 Operating activities from continuing operations         Net earnings (loss) attributable to Shareholders for the period 5 (20) 18 94 Net loss (earnings) from discontinued operations for the period - 2 2 (113) Net earnings (loss) from continuing operations 5 (18) 20 (19) Adjustments for           Financing expense 25 24 75 75   Depreciation and amortization 47 46 141 129   Gain on disposals and others - - (1) (10)   Impairment charges and restructuring costs (1) 14 1 18   Loss (gain) on derivative financial instruments (6) 11 (6) 11   Foreign exchange loss (gain) on long-term debt and financial instruments 5 (5) (2) 5   Provision for (recovery of) income taxes 1 10 7 (25)   Share of loss (earnings) of associates and joint ventures 1 (1) (3) (11)   Net loss attributable to non-controlling interest (1) (3) (3) (3)   Net financing expense paid (15) (14) (65) (65)   Income taxes paid (10) (4) (20) (13)   Dividends received 5 - 5 -   Others (14) - (22) (1)   42 60 127 91 Changes in non-cash working capital components 12 (19) (16) (89)   54 41 111 2 Investing activities from continuing operations         Investments in associates and joint ventures - (45) (19) (47) Purchases of property, plant and equipment (33) (31) (114) (90) Proceeds on disposal of property, plant and equipment 10 8 20 10 Change in other assets (2) 40 (29) 9 Business acquisitions, net of cash acquired - (3) (14) (4) Proceeds on disposals of business, net of cash disposed - - - 6   (25) (31) (156) (116) Financing activities from continuing operations         Bank loans and advances 8 6 7 29 Change in revolving credit facilities (38) (9) 104 (266) Purchase of senior notes - - (3) - Payments of other long-term debt (5) (4) (43) (13) Increase in other long-term debt 1 - 2 1 Redemption of common shares (1) (4) (3) (8) Partial disposal of a subsidiary to non-controlling interest - - 3 - Acquisition of non-controlling interest (1) (2) (2) (2) Dividends paid to the Corporation's Shareholders (3) (4) (11) (12)   (39) (17) 54 (271) Change in cash and cash equivalents during the period from continuing operations (10) (7) 9 (385) Change in cash and cash equivalents from discontinued operations, including proceeds on disposal during the period (3) - (5) 390 Net change in cash and cash equivalents during the period (13) (7) 4 5 Cash and cash equivalents?Beginning of period 29 18 12 6 Cash and cash equivalents?End of period 16 11 16 11 SEGMENTED INFORMATION In 2012, the Corporation changed the structure of its internal organization in a manner that caused the composition of its reportable segment to change. As a result, the Corporation modified its segmented information disclosure for the current period and restated prior periods. Containerboard and Boxboard North America manufacturing and converting activities are now presented within one segment. Boxboard European activities are reported as a separate segment. The Corporation's operations are managed in four segments: Containerboard, Boxboard Europe, Specialty Products (which consists of the Packaging Products of the Corporation) and Tissue Papers.   SALES   For the 3-month periods ended September 30, For the 9-month periods ended September  30, (in millions of Canadian dollars) (unaudited) 2012 2011 2012 2011 Packaging Products           Containerboard 299 317 883 994   Boxboard Europe 181 221 593 539   Specialty Products 197 224 608 645   Intersegment sales (17) (27) (54) (82)   660 735 2,030 2,096 Tissue Papers 253 221 737 638 Intersegment sales and others (7) (9) (26) (22) Total 906 947 2,741 2,712                       OPERATING INCOME (LOSS) BEFORE DEPRECIATION AND AMORTIZATION   For the 3-month periods ended September 30, For the 9-month periods ended September  30, (in millions of Canadian dollars) (unaudited) 2012 2011 2012 2011 Packaging Products           Containerboard 24 17 65 52   Boxboard Europe 8 8 30 35   Specialty Products 15 9 41 26   47 34 136 113 Tissue Papers 35 17 106 43 Corporate 1 2 (7) (5) Operating income before depreciation and amortization 83 53 235 151 Depreciation and amortization (47) (46) (141) (129) Financing expense (25) (24) (75) (75) Foreign exchange (loss) gain on long-term debt and financial instruments (5) 5 2 (5) Share of earnings (loss) of associates and joint ventures (1) 1 3 11 Profit (loss) before income taxes 5 (11) 24 (47)           PURCHASES OF PROPERTY, PLANT AND EQUIPMENT   For the 3-month periods ended September 30, For the 9-month periods ended September  30, (in millions of Canadian dollars) (unaudited) 2012 2011 2012 2011 Packaging Products           Containerboard 16 11 47 30   Boxboard Europe 9 10 19 22   Specialty Products 3 6 10 15   28 27 76 67 Tissue Papers 1 2 13 17 Corporate 9 6 14 8 Total purchases 38 35 103 92 Proceeds on disposal of property, plant and equipment (10) (8) (20) (10) Capital-lease acquisitions (4) (3) (4) (4)   24 24 79 78 Purchases of property, plant and equipment included in trade and other payables          Beginning of period 9 15 25 18  End of period (10) (16) (10) (16) Purchases of property, plant and equipment net of proceeds on disposal 23 23 94 80 SUPPLEMENTAL INFORMATION ON NON-IFRS MEASURES Operating income before depreciation and amortization, earnings before interests, taxes, depreciation and amortization, operating income and cash flow from operations are not measures of performance under IFRS. The Corporation includes operating income before depreciation and amortization, earnings before interests, taxes, depreciation and amortization, operating income and cash flow from operations because they are measures used by management to assess the operating and financial performance of the Corporation's operating segments. Additionally, the Corporation believes that these items provide additional measures often used by investors to assess a company's operating performance and its ability to meet debt service requirements. However, operating income before depreciation and amortization, earnings before interests, taxes, depreciation and amortization, operating income and cash flow from operations do not represent, and should not be used as a substitute for net earnings or cash flows from operating activities as determined in accordance with IFRS, and they are not necessarily an indication of whether cash flow will be sufficient to fund our cash requirements. In addition, our definition of operating income before depreciation and amortization, earnings before interests, taxes, depreciation and amortization, operating income and cash flow from operations may differ from those of other companies. Cash flow from operations is defined as cash flow from operating activities as determined in accordance with IFRS excluding the change in working capital components. Operating income before depreciation and amortization excluding specific items, earnings before interests, taxes, depreciation and amortization excluding specific items, operating income excluding specific items, net earnings excluding specific items, net earnings per common share excluding specific items and cash flow from operations excluding specific items are non-IFRS measures. The Corporation believes that it is useful for investors to be aware of specific items that have adversely or positively affected its IFRS measures, and that the above mentioned non-IFRS measures provide investors with a measure of performance  with which to compare its results between periods without regard to these specific items. The Corporation's measures excluding specific items have no standardized meaning prescribed by IFRS and are not necessarily comparable to similar measures presented by other companies and therefore should not be considered in isolation. Specific items are defined to include charges for impairment of assets, charges for facility or machine closures, accelerated depreciation of assets due to restructuring measures, debt restructuring charges, gains or losses on sale of business unit, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, foreign exchange gains or losses on long-term debt and other significant items of an unusual or non-recurring nature. The following table reconciles net earnings (loss) and net earnings (loss) per share to net earnings (loss) excluding specific items and net earnings (loss) per share excluding specific items:                 (in millions of Canadian dollars, except amounts per share) (unaudited) Net earnings (loss)    Net earnings (loss) per share1   Q3/2012 Q3/2011 Q2/2012   Q3/2012 Q3/2011 Q2/2012                 As per IFRS 5 (20) 7   $0.05 $(0.21) $0.08 Specific items :               Impairment charges 1 14 1   $ - $0.10 $0.01 Restructuring costs - 1 4   $ - $0.01 $0.03 Unrealized loss (gain) on financial instruments (6) 11 2   $(0.04) $0.10 $0.01 Accelerated depreciation and amortization due to restructuring measures 2 - 1   $0.01 $ - $0.01 Foreign exchange loss (gain) on long-term debt and financial instruments 5 (5) (5)   $0.05 $(0.05) $(0.05) Share of loss (earnings) of associates, joint ventures and non-controlling interest - 1 (2)   $ - $0.01 $(0.01) Included in discontinued operations, net of tax - 2 -   $ - $0.02 $ - Tax effect on specific items and other tax adjustments - (6) (1)   $ - $ - $ -   2 18 -   $0.02 $0.19 $ - Excluding specific items 7 (2) 7   $0.07 $(0.02) $0.08 Note 1 - Specific amounts per share are calculated on an after-tax basis.               Per share amounts of line item "Tax effect on specific items and other tax adjustments" only include the effect of tax adjustments.  Net earnings (loss), which is a performance measure defined by IFRS is reconciled below to operating income (loss), operating income excluding specific items and operating income before depreciation excluding specific items or earnings before interests, taxes, depreciation and amortization excluding specific items:         (in millions of Canadian dollars) (unaudited) Q3/2012 Q3/2011 Q2/2012         Net earnings 5 (20) 7 Net loss from discontinued operations for the period - 2 - Net loss attributable to non-controlling interest (1) (3) (1) Share of loss (earnings) of associates and joint ventures 1 (1) (2) Provision for income taxes 1 10 5 Foreign exchange loss (gain) on long-term debt and financial instruments 5 (5) (5) Financing expense 25 24 25         Operating income 36 7 29 Specific items :       Impairment charges 1 14 1 Restructuring costs - 1 4 Unrealized loss (gain) on financial instruments (6) 11 2 Accelerated depreciation and amortization due to restructuring measures 2 - 1   (3) 26 8         Operating income - excluding specific items 33 33 37 Depreciation and amortization, excluding specific items 45 46 47 Operating income before depreciation and amortization (OIBD or EBITDA) - excluding specific items 78 79 84 The following table reconciles cash flow provided by (used from) operating activities to cash flow (adjusted) from operations excluding specific items:           Cash flow from operations (in millions of Canadian dollars) (unaudited) Q3/2012 Q3/2011 Q2/2012         Cash flow provided by (used from) operating activities 54 41 33 Changes in non-cash working capital components (12) 19 4 Cash flow (adjusted) from operations 42 60 37 Specific items, net of current income tax       Restructuring costs 2 1 3 Excluding specific items 44 61 40     SOURCE CASCADES INC.For further information: <p> <b>Media: </b><br/> Christine Beaulieu <br/> Director of communications <br/> 819 363-5161 </p> <p> <b>Source: </b><br/> Allan Hogg<br/> Vice-President and Chief Financial Officer<br/> <br/> <b>Investors: </b><br/> Riko Gaudreault <br/> Director, Investor relations <br/> 514 282-2697 <br/> <br/> <b>Also follow us on social medias:</b><br/> Website: <a href="http://www.cascades.com">www.cascades.com</a><br/> Twitter: <a href="http://www.twitter.com/@CascadesInvest">twitter.com/@CascadesInvest</a><br/> Facebook : <a href="http://www.facebook.com/Cascades">facebook.com/Cascades</a><br/> YouTube : <a href="http://www.youtube.com/Cascades">youtube.com/Cascades</a> </p>